Literature DB >> 8883618

Primate models for AIDS vaccine development.

J L Heeney1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8883618     DOI： 10.1097/00002030-199601001-00016

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  4 in total

1.  beta-chemokines and neutralizing antibody titers correlate with sterilizing immunity generated in HIV-1 vaccinated macaques.

Authors:  J L Heeney; V J Teeuwsen; M van Gils; W M Bogers; C De Giuli Morghen; A Radaelli; S Barnett; B Morein; L Akerblom; Y Wang; T Lehner; D Davis
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

2.  Characteristics of a pathogenic molecular clone of an end-stage serum-derived variant of simian immunodeficiency virus (SIV(F359)).

Authors:  L Holterman; R Dubbes; J Mullins; G Learn; H Niphuis; W Koornstra; G Koopman; E M Kuhn; A Wade-Evans; B Rosenwirth; J Haaijman; J Heeney
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

3.  A pathogenic threshold of virus load defined in simian immunodeficiency virus- or simian-human immunodeficiency virus-infected macaques.

Authors:  P Ten Haaft; B Verstrepen; K Uberla; B Rosenwirth; J Heeney
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

4.  Protection against SHIV-KB9 infection by combining rDNA and rFPV vaccines based on HIV multiepitope and p24 protein in Chinese rhesus macaques.

Authors:  Chang Li; Zhenwei Shen; Xiao Li; Jieying Bai; Lin Zeng; Mingyao Tian; Ying Jin Song; Ming Ye; Shouwen Du; Dayong Ren; Cunxia Liu; Na Zhu; Dandan Sun; Yi Li; Ningyi Jin
Journal:  Clin Dev Immunol       Date:  2012-02-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.